Other Restructuring
What happened
FactOther Restructuring. Composite Scheme of Arrangement and Amalgamation amongst Steriscience Specialties Private Limited. 1947, and the rules made thereunder, subject to the approval of shareholders, creditors, stock exchanges.
Why it matters
CapitSignal interpretationA merger fixes a share-exchange ratio, which permanently sets how much of the combined company existing holders own.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
DelayedEBITDA at ₹173 million, down 88% YoY, due to lower revenue in the quarter and largely fixed cost base
EBITDA has also come in at INR1,233 million, which has been up significantly, 39% year-on-year, as well as sequentially 34% versus last quarter, and which has been in line when we have said last time that we will be showing a sequential quarter-on-quarter growth.
Change
FactImplication
CapitSignal interpretationMargins
WithdrawnEBITDA has also come in at INR1,233 million, which has been up significantly, 39% year-on-year, as well as sequentially 34% versus last quarter, and which has been in line when we have said last time that we will be showing a sequential quarter-on-quarter growth.
there's a significant improvement in margins which primarily coming from higher contribution from the drug device combination business
Change
FactImplication
CapitSignal interpretationMargins
WithdrawnEBITDA at ₹173 million, down 88% YoY, due to lower revenue in the quarter and largely fixed cost base
Q3FY26 revenue shortfall resulted in unfavourable operating leverage
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Swap ratio and its valuation basis
- Regulatory and NCLT approvals required
- Appointed date
- you will see, this addition will be a significant contributor to our FY28 numbers (management committed by FY28)
- $400 million in organic revenue with 40% EBITDA margin (management committed by FY28)
Evidence
- Onesource Specialty Pharma Limited has informed the Exchange about Other Restructuring(opens the original filing in a new tab)
- Earlier statement · Q3 FY26
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q3 FY26
- Latest statement · Q3 FY26
How CapitSignal classified this
- Reasoning:
- MERGER base 74; +4 corroborating keywords; +5 quantified amount; distress keyword present but no insolvency/default evidence — demoted; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%